Jaan Biotherapeutics
PrivateLast Round
Accelerator
Dec 11, 2025
Total Funding Raised
$3.44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jaan Biotherapeutics is a biotechnology company that develops novel therapies intended for regenerating damaged heart tissue in patients with cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jaan Biotherapeutics Comparables
Compare Jaan Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heqet Therapeutics | 85% | |
| Medley Therapeutics, Inc. | 77% | |
| Renova Therapeutics | 77% |
Jaan Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 11, 2025 | ||||
| Grant | Oct 6, 2025 | ||||
| Grant | Sep 8, 2020 | ||||
| Grant | Mar 16, 2017 |
Jaan Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Charles River Incubator Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
Received funding from Charles River Incubator Program.
- Nov 9, 2025
Monthly visitors grew 100% MoM, reaching 2.9K.
Jaan Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jaan Biotherapeutics's valuation, stock price, and market status.
Is Jaan Biotherapeutics a public or private company?
Jaan Biotherapeutics is a private company.
What is the current stock price of Jaan Biotherapeutics?
Jaan Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Jaan Biotherapeutics worth (valuation)?
Valuation information for Jaan Biotherapeutics is not publicly available.
Can I buy Jaan Biotherapeutics stock?
Jaan Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Jaan Biotherapeutics's last funding round?
Jaan Biotherapeutics's most recent funding round was Accelerator on December 11, 2025.
Who are the main investors in Jaan Biotherapeutics?
Key investors in Jaan Biotherapeutics include NIH RADx, National Heart, Lung, and Blood Institute, Charles River Incubator Program.
Will Jaan Biotherapeutics IPO soon?
No public IPO plans have been announced for Jaan Biotherapeutics.
How can I track Jaan Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jaan Biotherapeutics's secondary market activity and sign up for updates.